{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:34:51Z","timestamp":1761921291581,"version":"3.30.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jss.2024.10.010","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T17:49:18Z","timestamp":1731520158000},"page":"136-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Adjuvant Radioactive Iodine Ablation in Tall Cell Subtype Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"304","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-9543","authenticated-orcid":false,"given":"Phillip","family":"Staibano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay","family":"Alresaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keean","family":"Nanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Oulousian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Senthilkumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Oulousian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse D.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"McKechnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2024.10.010_bib1","doi-asserted-by":"crossref","first-page":"E612","DOI":"10.9778\/cmajo.20160162","article-title":"Thyroid cancer incidence in Canada: a national cancer registry analysis","volume":"5","author":"Topstad","year":"2017","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jss.2024.10.010_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.2013.0045","article-title":"The increasing incidence of thyroid cancer: the influence of access to care","volume":"23","author":"Morris","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2024.10.010_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221135447","article-title":"The incidence trend of papillary thyroid carcinoma in the United States during 2003-2017","volume":"29","author":"Li","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.jss.2024.10.010_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/clinem\/dgac739","article-title":"Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm","volume":"108","author":"Lee","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaoncol.2019.6851","article-title":"Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma","volume":"6","author":"Ho","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2024.10.010_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaoto.2022.3781","article-title":"Risk factors associated with recurrence and death in patients with tall cell papillary thyroid cancer: a single-institution cohort study with predictive nomogram","volume":"149","author":"Wu","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jss.2024.10.010_bib7","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1210\/clinem\/dgad580","article-title":"Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant","volume":"109","author":"Dai","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib8","article-title":"Radioactive iodine in low- to intermediate-risk papillary thyroid cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jss.2024.10.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2024.10.010_bib10","article-title":"The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2024.10.010_bib11","article-title":"Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jss.2024.10.010_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1200\/JCO.22.00013","article-title":"Radioactive iodine: recognizing the need for risk-benefit balance","volume":"40","author":"McDonald","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2024.10.010_bib13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/cancers15072152","article-title":"Outcomes of the tall-cell variant of papillary thyroid carcinoma in patients with different ages: a 17-year mono-institutional experience","volume":"15","author":"Proietti","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2024.10.010_bib14","doi-asserted-by":"crossref","first-page":"40792","DOI":"10.18632\/oncotarget.8215","article-title":"Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2024.10.010_bib15","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/325602","article-title":"Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis","volume":"2010","author":"Jalisi","year":"2010","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.jss.2024.10.010_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/thy.2008.0164","article-title":"Livolsi VA Papillary thyroid carcinoma tall cell variant","volume":"18","author":"Ghossein","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2024.10.010_bib17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jss.2024.10.010_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318787720","article-title":"The prognostic significance of tall cells in papillary thyroid carcinoma: a case-control study","volume":"40","author":"Stenman","year":"2018","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jss.2024.10.010_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13643-019-1188-0","article-title":"Saldanha IJ How should systematic reviewers handle conference abstracts? A view from the trenches","volume":"8","author":"Scherer","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.jss.2024.10.010_bib20","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jss.2024.10.010_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jss.2024.10.010_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"J Clin Epidemiol"},{"year":"2023","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","key":"10.1016\/j.jss.2024.10.010_bib23"},{"key":"10.1016\/j.jss.2024.10.010_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2023.02.014","article-title":"Systematic reviews and meta-analyses that include registry-based studies: methodological challenges and areas for future research","volume":"156","author":"Mathes","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jss.2024.10.010_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.surg.2021.05.054","article-title":"Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm","volume":"171","author":"Holoubek","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2024.10.010_bib26","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1245\/s10434-011-2129-x","article-title":"Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients","volume":"19","author":"Kazaure","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2024.10.010_bib27","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jamcollsurg.2019.08.187","article-title":"Overall survival in aggressive variants of papillary thyroid cancer","volume":"229","author":"Khokar","year":"2019","journal-title":"J Am Coll Surgeons"},{"key":"10.1016\/j.jss.2024.10.010_bib28","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1245\/s10434-018-6542-2","article-title":"Central lymph node status has significant prognostic value in the clinically node-negative tall-cell variant of papillary thyroid cancer regardless of T-staging and radioactive iodine administration: first evidence from a population-based study","volume":"25","author":"Shi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2024.10.010_bib29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.15537\/smj.2016.11.15480","article-title":"Tall cell variant papillary thyroid carcinoma in Saudi patients: a clinicopathological and outcomes analysis","volume":"37","author":"Al-Qahtani","year":"2016","journal-title":"Saudi Med J"},{"key":"10.1016\/j.jss.2024.10.010_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MLG.0b013e318156f6c3","article-title":"Law SC Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma","volume":"118","author":"Leung","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jss.2024.10.010_bib31","first-page":"11","article-title":"ETA Consensus Statement: what are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?","volume":"2022","author":"Pacini","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jss.2024.10.010_bib32","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1245\/s10434-019-07444-2","article-title":"Papillary thyroid cancers with focal tall cell change are as aggressive as tall cell variants and should not be considered as low-risk disease","volume":"26","author":"Bongers","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2024.10.010_bib33","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1210\/clinem\/dgad171","article-title":"Verburg FA adjuvant radioiodine for intermediate-risk papillary thyroid cancer-to treat or not to treat","volume":"108","author":"van Velsen","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib34","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/clinem\/dgad045","article-title":"Radioactive iodine therapy decreases the recurrence of intermediate-risk PTC with low thyroglobulin levels","volume":"108","author":"Tian","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12022-023-09788-8","article-title":"A critical assessment of diagnostic criteria for the tall cell subtype of papillary thyroid carcinoma-how much? How tall? And when is it relevant?","volume":"34","author":"Turchini","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jss.2024.10.010_bib36","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/lary.30725","article-title":"Utilizing dynamic risk stratification in patients with tall cell variant papillary thyroid cancer","volume":"133","author":"Zimmer","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jss.2024.10.010_bib37","doi-asserted-by":"crossref","first-page":"e4109","DOI":"10.1210\/clinem\/dgab388","article-title":"Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management","volume":"106","author":"Poma","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib38","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1210\/jc.2014-4332","article-title":"Sosa JA Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer","volume":"100","author":"Ruel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2024.10.010_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.2008.0392","article-title":"Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis","volume":"19","author":"Sawka","year":"2009","journal-title":"Thyroid"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424006620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424006620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:26:11Z","timestamp":1733999171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480424006620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0022480424006620"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2024.10.010","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Radioactive Iodine Ablation in Tall Cell Subtype Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2024.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}